- Home
- LLY
as 05-30-2025 4:00pm EST
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
| Founded: | 1876 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 652.7B | IPO Year: | N/A |
| Target Price: | $1014.22 | AVG Volume (30 days): | 4.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 12.29 | EPS Growth: | 80.99 |
| 52 Week Low/High: | $677.09 - $972.53 | Next Earning Date: | 05-01-2025 |
| Revenue: | $49,003,200,000 | Revenue Growth: | 36.38% |
| Revenue Growth (this year): | 33.15% | Revenue Growth (next year): | 19.62% |
Stock Insider Trading Activity of Eli Lilly and Company (LLY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | LLY | 10% Owner | Mar 3 '25 | Sell | $928.71 | 220,000 | $204,326,150.89 | 96,218,150 |
Latest Eli Lilly and Company News
LLY Breaking Stock News: Dive into LLY Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates
Motley Fool
a day ago
3 American Growth Giants to Invest in for the Long Haul
Quartz
2 days ago
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
PR Newswire
2 days ago
Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions
Insider Monkey
2 days ago
Was Jim Cramer Right About Eli Lilly and Company (LLY)?
Barrons.com
2 days ago
Heart Disease Could Be a Goner When These New Drugs Arrive
Zacks
2 days ago
PFE or LLY: Which Is the Better Value Stock Right Now?
Investor's Business Daily
2 days ago
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Compare LLY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LLY Eli Lilly and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.